Lucisot is used for treating KRAS G12C mutation-positive
lung cancer. It is a precision medicine approach in oncology.
Active Ingredient
Sotorasib inhibits KRAS G12C protein.
Uses of Lucisot
• KRAS-mutated NSCLC
How Lucisot Works
It blocks abnormal KRAS signaling, reducing tumor growth.
How to Use Lucisot
• Take once daily
Possible Side Effects
• Diarrhea
• Fatigue
Precautions
• Monitor liver function
Safety Information
Use under medical supervision.
Storage
• Store at room temperature
• Keep away from moisture
• Keep out of reach of children